View Item 

Show simple item record

PDX1â MODY and dorsal pancreatic agenesis: New phenotype of a rare disease
dc.contributor.authorCaetano, L.A.
dc.contributor.authorSantana, L.S.
dc.contributor.authorCosta‐riquetto, A.d.
dc.contributor.authorLerario, A.M.
dc.contributor.authorNery, M.
dc.contributor.authorNogueira, G.F.
dc.contributor.authorOrtega, C.D.
dc.contributor.authorRocha, M.S.
dc.contributor.authorJorge, A.A.L.
dc.contributor.authorTeles, M.G.
dc.date.accessioned2018-02-05T16:45:02Z
dc.date.available2019-04-01T15:01:10Zen
dc.date.issued2018-02
dc.identifier.citationCaetano, L.A.; Santana, L.S.; Costa‐riquetto, A.d. ; Lerario, A.M.; Nery, M.; Nogueira, G.F.; Ortega, C.D.; Rocha, M.S.; Jorge, A.A.L.; Teles, M.G. (2018). "PDX1â MODY and dorsal pancreatic agenesis: New phenotype of a rare disease." Clinical Genetics 93(2): 382-386.
dc.identifier.issn0009-9163
dc.identifier.issn1399-0004
dc.identifier.urihttps://hdl.handle.net/2027.42/142027
dc.publisherBlackwell Publishing Ltd
dc.publisherWiley Periodicals, Inc.
dc.subject.otherMODY
dc.subject.otherdorsal pancreatic agenesis
dc.subject.otherPDX1
dc.subject.otherheterozygous variant
dc.titlePDX1â MODY and dorsal pancreatic agenesis: New phenotype of a rare disease
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelGenetics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/142027/1/cge13044_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/142027/2/cge13044-sup-0002-SuppMethods.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/142027/3/cge13044.pdf
dc.identifier.doi10.1111/cge.13044
dc.identifier.sourceClinical Genetics
dc.identifier.citedreferenceSchwitzgebel VM, Mamin A, Brun T, et al. Agenesis of human pancreas due to decreased halfâ life of insulin promoter factor 1. J Clin Endocrinol Metab. 2003; 88 ( 9 ): 4398 â 4406.
dc.identifier.citedreferenceThomas IH, Saini NK, Adhikari A, et al. Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPFâ 1 Pro63fsX60 mutation. Pediatr Diabetes. 2009; 10 ( 7 ): 492 â 496.
dc.identifier.citedreferenceFujimoto K, Polonsky KS. Pdx1 and other factors that regulate pancreatic betaâ cell survival. Diabetes Obes Metab. 2009; 11 ( Suppl 4 ): 30 â 37.
dc.identifier.citedreferenceJohnson JD, Ahmed NT, Luciani DS, et al. Increased islet apoptosis in Pdx1+/â mice. J Clin Invest. 2003; 111 ( 8 ): 1147 â 1160.
dc.identifier.citedreferenceBrissova M, Shiota M, Nicholson WE, et al. Reduction in pancreatic transcription factor PDXâ 1 impairs glucoseâ stimulated insulin secretion. J Biol Chem. 2002; 277 ( 13 ): 11225 â 11232.
dc.identifier.citedreferenceCockburn BN, Bermano G, Boodram LL, et al. Insulin promoter factorâ 1 mutations and diabetes in Trinidad: identification of a novel diabetesâ associated mutation (E224K) in an Indoâ Trinidadian family. J Clin Endocrinol Metab. 2004; 89 ( 2 ): 971 â 978.
dc.identifier.citedreferenceFajans SS, Bell GI, Paz VP, et al. Obesity and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the IPF1 mutation Pro63fsX60. Transl Res. 2010; 156 ( 1 ): 7 â 14.
dc.identifier.citedreferenceRichards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17 ( 5 ): 405 â 424.
dc.identifier.citedreferenceMurphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic betaâ cell diabetes. Nat Clin Pract Endocrinol Metab. 2008; 4 ( 4 ): 200 â 213.
dc.identifier.citedreferenceNicolino M, Claiborn KC, Senee V, Boland A, Stoffers DA, Julier C. A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency. Diabetes. 2010; 59 ( 3 ): 733 â 740.
dc.identifier.citedreferenceStoffers DA, Ferrer J, Clarke WL, Habener JF. Earlyâ onset typeâ II diabetes mellitus (MODY4) linked to IPF1. Nat Genet. 1997; 17 ( 2 ): 138 â 139.
dc.identifier.citedreferenceStoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet. 1997; 15 ( 1 ): 106 â 110.
dc.identifier.citedreferenceHaldorsen IS, Raeder H, Vesterhus M, Molven A, Njolstad PR. The role of pancreatic imaging in monogenic diabetes mellitus. Nat Rev Endocrinol. 2011; 8 ( 3 ): 148 â 159.
dc.identifier.citedreferenceLango Allen H, Flanagan SE, Shawâ Smith C, et al. GATA6 haploinsufficiency causes pancreatic agenesis in humans. Nat Genet. 2011; 44 ( 1 ): 20 â 22.
dc.identifier.citedreferenceChapla A, Mruthyunjaya MD, Asha HS, et al. Maturity onset diabetes of the young in India â a distinctive mutation pattern identified through targeted nextâ generation sequencing. Clin Endocrinol (Oxf). 2015; 82 ( 4 ): 533 â 542.
dc.identifier.citedreferenceAnik A, Catli G, Abaci A, et al. Molecular diagnosis of maturityâ onset diabetes of the young (MODY) in Turkish children by using targeted nextâ generation sequencing. J Pediatr Endocrinol Metab. 2015; 28 ( 11â 12 ): 1265 â 1271.
dc.identifier.citedreferenceServitja JM, Ferrer J. Transcriptional networks controlling pancreatic development and beta cell function. Diabetologia. 2004; 47 ( 4 ): 597 â 613.
dc.identifier.citedreferenceMangrum C, Rush E, Shivaswamy V. Genetically targeted dipeptidyl peptidaseâ 4 inhibitor use in a patient with a novel mutation of MODY type 4. Clin Med Insights Endocrinol Diabetes. 2015; 8: 83 â 86.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cge13044_am.pdf
Size:
1.825MB
Format:
PDF
View/Open
Name:
cge13044-sup-0002-SuppMethods.pdf
Size:
7.772KB
Format:
PDF
View/Open
Name:
cge13044.pdf
Size:
929.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.